Table 2.

Review progress and workload implications during the pilot period

Review topica	Anti-coagulation in people with cancer (3 related LSRs)b	Fruit and vegetable consumption in children	Delayed antibiotics for respiratory infections	Zika virus and adverse neurological outcomes	Adherence to guidelines in traumatic brain injury	Epidemiology of traumatic brain injury
Date ‘baseline’ review published	LSR 1c: September 2017 LSR 2d: December 2017 LSR 3e: June 2018	September 2017	September 2017	February 2018	October 2015	November 2015
No. of studies in ‘baseline’ publication	LSR 1c: 19 LSR 2d: 7 LSR 3e: 16	50	11	101	22	66
No. of new studies found since ‘baseline’ publicationf	5g	13	0	96	14	18
No. of status updates since baseline review	Monthly updates LSR 1c: 10 LSR 2d: 7 LSR 3e: 1	10	10	0	4	3
No. of times review re-published	07	2 (January and May 2018)	0	0	0	0

No. number

^aEach team produced one LSR unless otherwise stated

^bThese three LSRs were part of a suite of LSRs that used a single search

^cRefers to the first in the suite of LSRs published: Parenteral anticoagulation in ambulatory patients with cancer.

^dRefers to the second in the suite of LSRs published: Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

^eRefers to the third in the suite of LSRs published: Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

^fIncludes new (not ongoing) studies that were screened and found to meet the inclusion criteria for the review until the end of the pilot period

^gData presented for all three reviews (as appropriate, given they transitioned into living mode at different times during the pilot period) given the same search fed into all reviews and they were managed by the same author and editorial teams